ISRG vs BDX vs RMD
161 measures in 16 categories, one definition each, computed from filings and market data.
ISRG80.1
Intuitive Surgical, Inc.
Healthcare · Medical - Instruments & Supplies
$426.70 −0.27%$150.7B mkt cap
Score DNA
BDX42.6
Becton, Dickinson and Company
Healthcare · Medical - Instruments & Supplies
$191.75 −1.14%$52.2B mkt cap
Score DNA
RMD81.9
ResMed Inc.
Healthcare · Medical - Instruments & Supplies
$238.97 −1.35%$33.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
ISRG BDX RMD · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 5 | 1 | 3 |
| Last Congress purchase | 2026-09-25 | 2026-09-11 | 2026-09-11 |
| 13F net change in holders | −57 | — | −51 |
| ETFs adding shares, 30d | 1,370 | 380 | 1,058 |
| ETFs trimming, 30d | 1,202 | 401 | 859 |
| Net ETF funds, 30d | +168 | −21 | +199 |
Valuation
16 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| P/E (TTM) | 48.0x
60th
|
55.5x
67th
|
22.1x
27th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.60
71st
|
— | 1.10
43rd
|
| Price / sales | 13.7x
92nd
|
2.5x
54th
|
5.9x
79th
|
| Price / book | 8.3x
88th
|
2.1x
38th
|
5.1x
71st
|
| Price / tangible book | 8.2x
60th
|
— | 8.8x
67th
|
| Price / free cash flow | 46.8x
71st
|
20.0x
33rd
|
11.6x
5th
|
| Price / operating cash flow | 40.7x
73rd
|
15.7x
41st
|
10.6x
14th
|
| Enterprise value | $145.5B
100th
|
$68.3B
96th
|
$33.0B
88th
|
| EV / sales | 13.2x
92nd
|
3.3x
67th
|
5.8x
79th
|
| EV / EBITDA | 32.8x
75th
|
15.3x
35th
|
15.3x
30th
|
| EV / EBIT | 40.1x
76th
|
32.0x
47th
|
17.1x
18th
|
| EV / free cash flow | 45.2x
67th
|
26.2x
29th
|
11.4x
5th
|
| Earnings yield | 2.1%
64th
|
1.8%
60th
|
4.5%
84th
|
| FCF yield | 2.1%
40th
|
5.0%
72nd
|
8.6%
96th
|
| Operating cash flow yield | 2.5%
36th
|
6.4%
64th
|
9.4%
88th
|
| Graham number (per share) | $99.92
93rd
|
$82.63
79th
|
$103.63
100th
|
Profitability (TTM)
12 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Gross margin | 66.7%
84th
|
46.1%
32nd
|
61.2%
76th
|
| EBITDA margin | 40.3%
100th
|
21.4%
62nd
|
38.2%
96th
|
| Operating margin | 31.3%
96th
|
9.8%
50th
|
33.5%
100th
|
| EBIT margin | 32.9%
96th
|
10.2%
62nd
|
34.0%
100th
|
| Net margin | 28.4%
100th
|
4.5%
58th
|
26.9%
96th
|
| NOPAT margin | 26.0%
96th
|
8.0%
58th
|
26.6%
100th
|
| FCF margin | 29.2%
96th
|
12.5%
62nd
|
51.1%
100th
|
| Operating cash flow margin | 33.6%
96th
|
16.0%
67th
|
55.8%
100th
|
| R&D / revenue | 12.8%
88th
|
5.5%
42nd
|
6.7%
58th
|
| SG&A / revenue | 22.6%
21st
|
25.3%
29th
|
19.7%
12th
|
| Stock comp / revenue | 7.5%
84th
|
1.2%
40th
|
3.2%
72nd
|
| Effective tax rate | 17.0%
12th
|
18.9%
16th
|
20.6%
32nd
|
Returns on capital
11 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| ROE (on average equity) | 17.4%
88th
|
3.8%
67th
|
24.3%
96th
|
| ROA | 15.3%
96th
|
1.8%
64th
|
17.8%
100th
|
| ROIC | 22.1%
88th
|
4.1%
52nd
|
25.3%
92nd
|
| ROCE | 19.2%
88th
|
5.2%
56th
|
25.4%
96th
|
| Return on tangible assets | 17.7%
92nd
|
4.0%
52nd
|
22.4%
100th
|
| Cash ROIC (OCF / invested capital) | 28.6%
92nd
|
8.2%
48th
|
53.1%
100th
|
| Gross profitability (GP / assets) | 35.2%
76th
|
18.9%
28th
|
38.6%
80th
|
| ROIC, 3-yr average | 19.2%
95th
|
3.2%
57th
|
21.8%
100th
|
| ROIC, 5-yr average | 21.4%
90th
|
3.8%
62nd
|
26.2%
100th
|
| ROE, 5-yr average | 14.0%
90th
|
5.8%
67th
|
22.5%
100th
|
| Incremental ROIC | 216.9%
88th
|
-10.0%
29th
|
66.0%
62nd
|
Growth
17 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Revenue growth (TTM YoY) | 20.7%
91st
|
-2.6%
13th
|
9.9%
57th
|
| Revenue growth (QoQ) | 4.4%
40th
|
5.7%
56th
|
2.3%
20th
|
| Revenue CAGR, 3 yr | 18.3%
95th
|
3.0%
38th
|
10.2%
76th
|
| Revenue CAGR, 5 yr | 16.4%
89th
|
1.2%
26th
|
12.1%
79th
|
| Gross profit CAGR, 3 yr | 18.3%
90th
|
4.0%
62nd
|
13.6%
81st
|
| Operating income CAGR, 3 yr | 28.6%
79th
|
-3.1%
21st
|
18.7%
64th
|
| Net income growth (TTM YoY) | 20.4%
50th
|
-41.4%
0th
|
8.8%
30th
|
| Net income CAGR, 3 yr | 30.1%
91st
|
-17.3%
27th
|
19.3%
64th
|
| EPS growth (TTM YoY) | 22.3%
50th
|
-38.5%
0th
|
10.3%
30th
|
| EPS CAGR, 3 yr | 30.0%
91st
|
-16.0%
27th
|
20.0%
64th
|
| EPS CAGR, 5 yr | 14.5%
73rd
|
-12.6%
45th
|
26.5%
91st
|
| FCF growth (TTM YoY) | 61.6%
71st
|
2.2%
35th
|
74.2%
82nd
|
| FCF CAGR, 3 yr | 39.8%
71st
|
14.4%
43rd
|
72.9%
100th
|
| Operating cash flow CAGR, 3 yr | 25.9%
69th
|
8.2%
44th
|
65.7%
88th
|
| Book value CAGR, 3 yr | 15.1%
95th
|
-0.5%
38th
|
17.5%
100th
|
| Dividend CAGR, 3 yr | — | 16.2%
88th
|
26.1%
100th
|
| Sustainable growth rate | 17.4%
93rd
|
-3.3%
0th
|
14.5%
79th
|
Margin history & stability
7 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Gross margin, 3-yr average | 66.7%
82nd
|
44.4%
27th
|
58.9%
64th
|
| Operating margin, 3-yr average | 28.6%
95th
|
11.1%
59th
|
31.5%
100th
|
| Net margin, 3-yr average | 28.2%
100th
|
6.4%
59th
|
25.3%
95th
|
| FCF margin, 3-yr average | 18.9%
91st
|
13.6%
73rd
|
36.9%
100th
|
| Revenue stability (0-1) | 0.95
65th
|
0.53
22nd
|
1.00
100th
|
| Earnings stability (0-1) | 0.81
83rd
|
0.78
74th
|
0.97
100th
|
| Margin stability (0-1) | 0.99
91st
|
0.96
41st
|
0.96
45th
|
Liquidity (latest quarter)
7 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Cash & short-term investments | $5.2B
100th
|
$709.0M
76th
|
$1.5B
88th
|
| Net cash (− = net debt) | $5.2B
100th
|
−$16.1B
0th
|
$643.3M
96th
|
| Working capital | $7.6B
96th
|
−$1.3B
0th
|
$2.9B
88th
|
| Current ratio | 4.96
88th
|
0.87
0th
|
3.10
64th
|
| Quick ratio | 3.91
80th
|
0.51
0th
|
2.42
64th
|
| Cash ratio (cash + ST investments / current liabilities) | 2.71
84th
|
0.08
0th
|
1.05
56th
|
| Defensive interval (days) | 653 days
88th
|
148 days
8th
|
584 days
76th
|
Leverage & solvency (latest quarter)
13 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Total debt | $0
0th
|
$16.8B
100th
|
$825.9M
48th
|
| Debt / equity | 0.00
0th
|
0.69
71st
|
0.13
25th
|
| Net debt / equity | −0.29
17th
|
0.66
71st
|
−0.10
33rd
|
| Debt / assets | 0.0%
0th
|
33.1%
72nd
|
9.2%
24th
|
| Debt / capital | 0.0%
0th
|
40.8%
71st
|
11.1%
25th
|
| Debt / EBITDA | 0.00
0th
|
3.77
50th
|
0.38
10th
|
| Net debt / EBITDA | −1.17
15th
|
3.61
65th
|
−0.30
25th
|
| Interest coverage (EBIT / interest) | — | 3.9x
62nd
|
66.2x
95th
|
| Cash interest coverage | — | 6.1x
57th
|
108.8x
95th
|
| Debt payback (years of OCF) | 0.0 yrs
0th
|
5.0 yrs
45th
|
0.3 yrs
5th
|
| Liabilities / assets | 12.4%
0th
|
51.9%
72nd
|
26.6%
20th
|
| IS credit model rating | AA | BB+ | AAA |
| Implied credit spread (bps) | 80
8th
|
400
60th
|
50
0th
|
Efficiency
11 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Asset turnover | 0.54
44th
|
0.39
28th
|
0.66
72nd
|
| Fixed asset turnover | 1.99
16th
|
3.43
44th
|
7.69
84th
|
| Inventory turnover | 2.0
16th
|
3.1
56th
|
2.3
40th
|
| Receivables turnover | 7.9
84th
|
7.9
80th
|
5.7
32nd
|
| Days sales outstanding | 46 days
16th
|
46 days
20th
|
64 days
68th
|
| Days inventory outstanding | 183 days
84th
|
118 days
44th
|
156 days
60th
|
| Days payables outstanding | 27 days
8th
|
103 days
88th
|
49 days
40th
|
| Cash conversion cycle (days) | 202 days
84th
|
61 days
12th
|
171 days
68th
|
| Capex / revenue | 4.4%
54th
|
3.5%
42nd
|
4.7%
62nd
|
| Capex / depreciation | 0.60
67th
|
0.31
21st
|
1.14
92nd
|
| Operating expense ratio | 34.2%
29th
|
33.2%
25th
|
28.2%
21st
|
Cash flow & earnings quality
7 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Operating cash flow / net income | 1.18
20th
|
3.54
80th
|
2.07
60th
|
| FCF / net income | 1.03
27th
|
2.77
80th
|
1.90
60th
|
| FCF / operating cash flow | 86.9%
76th
|
78.2%
62nd
|
91.5%
90th
|
| Capex / operating cash flow | 13.1%
24th
|
21.8%
38th
|
8.5%
10th
|
| Accruals ratio | -2.8%
84th
|
-4.5%
60th
|
-19.1%
12th
|
| Sloan accruals ratio | -1.2%
60th
|
-8.4%
16th
|
2.4%
80th
|
| Earnings quality score (0-1) | 1.00
47th
|
1.00
47th
|
0.75
13th
|
Scores & forensic checks
15 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| IS score | 80
96th
|
43
48th
|
82
100th
|
| IS profitability | 89
96th
|
33
52nd
|
93
100th
|
| IS growth | 70
91st
|
18
0th
|
55
43rd
|
| IS value | 33
8th
|
43
52nd
|
63
92nd
|
| IS momentum | 92
91st
|
53
39th
|
81
65th
|
| IS risk (safety) | 100
72nd
|
50
16th
|
100
72nd
|
| IS quality | 91
96th
|
68
60th
|
93
100th
|
| IS balance sheet | 96
100th
|
42
28th
|
91
92nd
|
| IS earnings quality | 76
80th
|
80
92nd
|
44
40th
|
| IS cash flow | 87
96th
|
59
64th
|
99
100th
|
| Piotroski F-score (0-9) | 7
68th
|
6
48th
|
7
68th
|
| Altman Z-score | 35.2
96th
|
2.0
28th
|
10.0
88th
|
| Beneish M-score | −2.41
87th
|
−2.91
35th
|
−3.29
17th
|
| Ohlson O-score | −13.79
0th
|
−8.24
56th
|
−12.34
4th
|
| IS credit score | 89
88th
|
46
24th
|
96
96th
|
Size (TTM)
8 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| Market cap | $150.7B
100th
|
$52.2B
96th
|
$33.6B
92nd
|
| Revenue | $11.0B
88th
|
$20.8B
96th
|
$5.7B
76th
|
| EBITDA | $4.4B
96th
|
$4.5B
100th
|
$2.2B
88th
|
| Net income | $3.1B
100th
|
$941.0M
88th
|
$1.5B
96th
|
| Free cash flow | $3.2B
100th
|
$2.6B
92nd
|
$2.9B
96th
|
| Total assets | $20.9B
92nd
|
$50.7B
100th
|
$9.0B
68th
|
| Shareholders' equity | $18.2B
96th
|
$24.4B
100th
|
$6.6B
84th
|
| Employees | 17,021
84th
|
72,000
100th
|
11,370
48th
|
Price performance
9 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| 1 day | −0.3% | −1.1% | −1.4% |
| 1 week | +0.7% | +4.2% | +3.9% |
| 1 month | +11.2% | +5.6% | +4.6% |
| 3 months | +20.8% | +24.0% | +20.3% |
| 6 months | −9.1% | +20.8% | +4.8% |
| Year to date | −24.1% | +25.0% | −2.2% |
| 1 year | −2.0% | +3.1% | −11.2% |
| 3 years, cumulative | +51.4% | −23.5% | +69.2% |
| 5 years, cumulative | +29.9% | −11.6% | −2.3% |
Technicals
4 measures| Measure | ISRG | BDX | RMD |
|---|---|---|---|
| RSI 14 | 64.7 | 63.4 | 66.5 |
| From 52-week high | −29.3% | −5.5% | −13.7% |
| From 52-week low | +29.9% | +36.7% | +32.6% |
| Beta | 1.46 | 0.28 | 0.75 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17